Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Anticonvulsants show promise in the management of impulsive aggression

March 30, 2005

Antiinflammatory and antiapoptotic properties of MX-1153

March 30, 2005

Cannabinoid CB1 antagonists active in advanced Parkinson's disease model

March 29, 2005

SGS-742 evaluated in new phase II study for adult ADHD

March 29, 2005

Patents covering treatments for pain disclosed

March 24, 2005

SR-142801 produces mixed results in panic disorder trial

March 24, 2005

Ropinirole demonstrates efficacy in restless legs syndrome

March 24, 2005

New clinical data on pramipexole in restless legs syndrome reported

March 24, 2005

Merck conducting active research of mGluR2 agonists

March 24, 2005

Xyrem sNDA accepted for review

March 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...